中药内服联合沐足对糖尿病足介入术后再狭窄的影响  

Influence of Oral Chinese Medicine Combined with Foot Bath on Restenosis after Percutaneous Coronary Intervention on Diabetes

作　　者：刘文导[1] 梅世伟[1] 孟凡喆[1] 郝淑芳[1] 梁晓聪[1] 常钢[1] 

机构地区：[1]广东省中医院,广东广州510120

出　　处：《中医药导报》2014年第13期15-17,共3页Guiding Journal of Traditional Chinese Medicine and Pharmacy

基　　金：广东省教育厅课题(广东高校优秀青年创新人才培养计划项目;编号:2013LYM_0013)

摘　　要：目的:探讨中药内服联合沐足对糖尿病足腔内血管成形介入术后再狭窄的影响。方法:将110例糖尿病足拟行下肢动脉腔内血管成形术的患者随机分为治疗组与对照组,两组均给以腔内血管成形术,治疗组术后予中药内服配合中药沐足治疗,对照组术后应用常规西医对症治疗,比较两组临床疗效、再狭窄率、踝肱指数(ABI)等情况。结果:治疗组治愈率、总有效率均优于对照组(P<0.05),再狭窄率明显降低(P<0.05),ABI值明显提高(P<0.05)。结论:中药内服联合沐足可降低糖尿病足腔内血管成形介入术后再狭窄率,提高糖尿病足介入治疗的临床疗效。Objective： To explore the influence of oral Chinese Medicine combined with foot bath on restenosis after per- cutaneous coronary intervention on diabetes. Methods： The 100 cases of patients with diabetes feet were randomly divided into treatment and control groups. Patients were treated by percutaneous Transluminal coronary angioplastyin both two groups. Pa- tients were given oral Chinese Medicine combined with foot bath in treatment group and conventional western medicine treat- ment in control group after the operation. The clinical efficacy, in-stent restenosis and ankle - brachial index （ABI） were compared between the two groups. Results： The treatment group showed better cure rate and the total efficiency than the con- trol group （P〈0.05）, lower in-stent restenosis than the control group （P〈0.05）, and higher ABI than the control group （P〈0. 05）. Conclusion： Oral Chinese Medicine combined with foot bath can reduce the restenosis after percutaneous coronary inter- vention on diabetes and improve the clinical efficacy.

关 键 词：糖尿病足 血管成形术 中药 沐足 再狭窄 

分 类 号：R255.4[医药卫生—中医内科学]